Candel Therapeutics Inc (CADL)
R&D Expense Growth
101.23%
Quarterly · Period ending:
CADL R&D Expense Growth
Latest reported101.23%period ending
Latest reported101.23%period ending
CADL Quarterly R&D Growth (QoQ) (0.00% → 101.23%)
Latest values, visible window
High-resolution chart · PNG
CADL r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 101.2297% | |
| -10.7726% | |
| 30.3392% | |
| 21.027% | |
| 74.0787% | |
| -16.6286% | |
| -11.0598% | |
| 8.7769% | |
| 21.3798% | |
| -43.4831% | |
| 24.1745% | |
| -1.4998% | |
| 8.5025% | |
| 16.4608% | |
| -12.6488% | |
| 7.049% | |
| -7.2919% | |
| 47.3613% | |
| -30.1804% | |
| 59.9332% | |
| 19.5786% | |
| -22.0996% | |
| 94.9255% | |
| 1.0028% | |
| 10.7341% | |
| 0% |